Capital Change Notice

19
th
October 2021

Notice of issue of options under Rua Bioscience Limited’s share option plan

This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of options (Options) to acquire
ordinary shares in Rua Bioscience Limited (the Company) pursuant to the terms of the share option plan
of the Company (the Share Option Plan).

This notice provides details of the issue of 2,486,400 Options to selected eligible employees of the
Company pursuant to the rules of the Share Option Plan.

Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of financial product Options to acquire ordinary shares in the
Company
ISIN (If unknown, check on NZX website) NZRUAE0004S1. The Options will not be
quoted.
Currency NZD
Section 2: Capital change details
Number of Options issued 2,486,400
Issue price per Option No cash consideration is payable for the
issue of the Options
Nature of the payment (for example, cash or other
consideration)
Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Options issued 100% of all Options of the same class
currently on issue.
The principal terms of the Options Subject to the rules of the Share Option
Plan and achievement of certain
performance hurdles assessed on 30 June
2024 (Vesting Date), each Option holder
will be able to exercise: one third of their
vested Options in the period from the
Vesting Date to the date that is one
calendar month after the Vesting Date;
one third of their vested Options in the
period from the first anniversary of the
MARKET ANNOUNCEMENT

Vesting Date to the date that is one
calendar month after the first anniversary
of the Vesting Date; and one third of their
vested Options in the period from the
second anniversary of the Vesting Date to
the date that is one calendar month after
the second anniversary of the Vesting
Date.
The exercise price is nil.
Reason for issue of the Options The board of the Company resolved to
offer Options to participants for the
purpose of:
(a) enabling the Company to recruit and
retain highly qualified personnel;
(b) incentivising increased productivity;
and
(c) providing the participants with an
opportunity to share in the growth and
value of the Company.
Total number of Options of the same class in existence
after the issue of the Options
2,486,400 Options following the issue of
the Options
Specific authority for the issue of the Options Directors’ resolution dated 15
th
October
2021. The Options were issued in
accordance with Listing Rules 4.6 and 4.11.
Terms of the issue of the Options The new ordinary shares issued upon the
exercise of the Options will be credited as
fully paid, and rank in all respects equally
with the ordinary shares already on issue
and will otherwise be issued in accordance
with the vesting requirements and terms
of the Share Option Plan
Date of issue of the Options 18/10/2021
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement
Hamish White, Chief Financial Officer of
Rua Bioscience Limited
Contact person for this announcement Kerry Donovan
Contact phone number +64 21 128 7689
Contact email address kerry.donovan@ruabio.com
Date of release through MAP 20/10/2021